Major Strides in HER2 Blockade for Metastatic Breast Cancer

N Engl J Med. 2020 Feb 13;382(7):669-671. doi: 10.1056/NEJMe1916310.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Breast Neoplasms*
  • Humans
  • Receptor, ErbB-2
  • Trastuzumab

Substances

  • Receptor, ErbB-2
  • Trastuzumab